Understanding how açaí supplements interact with cancer drugs
Unravelling the mechanism of acai BDS-anticancer drug interaction: A preliminary approach
This study is looking at how açaí supplements might affect cancer treatments, especially to see if they could cause any problems for patients taking both, so we can help make sure everyone gets the best care possible.
Quick facts
| Grant type | R15 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Auburn University at Auburn NIH-funded |
| Lab location | 1 site (Auburn, UNITED STATES) |
| Project ID | NIH-10291596 on NIH RePORTER |
What this research studies
This research investigates the interactions between açaí dietary supplements and anticancer medications, particularly focusing on how these interactions may lead to adverse events in cancer patients. The study aims to identify the mechanisms behind these interactions, which could involve various enzymes and drug transporters. By understanding these interactions, the research seeks to improve treatment outcomes for patients using açaí alongside their conventional cancer therapies.
Who could benefit from this research
Good fit: Ideal candidates for this research are cancer patients who are currently using or considering using açaí dietary supplements in conjunction with their anticancer medications.
Not a fit: Patients who are not using açaí supplements or those who are not undergoing treatment for cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could help prevent life-threatening side effects in cancer patients who use açaí supplements with their treatment.
How similar studies have performed: Previous research has indicated potential risks associated with the use of dietary supplements in cancer treatment, suggesting that this area of investigation is both relevant and necessary.
Where this research is happening
Auburn, UNITED STATES
- Auburn University at Auburn — Auburn, United States (Active)
Researchers
- Principal investigator: Calderon, Angela Isabel — Auburn University at Auburn
- Study coordinator: Calderon, Angela Isabel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.